Search

Showing "11155" results for ""

Screening for cryptococcal antigens in HIV-positive cohort shows benefits of targeted pre-emptive strategy

New UN drug policy will undermine HIV prevention

High HIV prevalence amongst men who have sex with men in Laos

European study confirms that HIV treatment within three months of birth improves outcome for HIV-positive infants

Ritonavir-boosted atazanavir as protease-only maintenance therapy: 48-week results

Efavirenz dose reduction safe for patients with gene associated with high drug levels and side-effects

Conference highlights the forces encouraging risk behaviour in gay men

Swiss study finds moderate drug resistance; highlights difficulty of interpreting trends in changing treatment populations

Circumcision trial shows how HIV and herpes amplify each other: circumcision protects against both

Scottish gay men’s testing rates only slightly increased between 1996 and 2005

High rate of anal HPV infection, low rate of clearance and significant new infections in HIV-positive gay men

HIV-positive women with a weak immune system more likely to have baby with growth retardation

Rate of transmitted drug-resistant HIV stable in France

International AIDS Society names NAM official conference news provider

Body-shape changes and lipid abnormalities common in HIV-positive children and young adults

Incomplete immune recovery still seen in some people with HIV after ten years of therapy

Isoniazid and ARVs reduce TB risk by 90% in two South African clinics

Slow progress in diagnosis and treatment of MDR-TB and XDR-TB

Receive the latest HIV research and conference news

Showing "11155" results for ""

Screening for cryptococcal antigens in HIV-positive cohort shows benefits of targeted pre-emptive strategy

New UN drug policy will undermine HIV prevention

High HIV prevalence amongst men who have sex with men in Laos

European study confirms that HIV treatment within three months of birth improves outcome for HIV-positive infants

Ritonavir-boosted atazanavir as protease-only maintenance therapy: 48-week results

Efavirenz dose reduction safe for patients with gene associated with high drug levels and side-effects

Conference highlights the forces encouraging risk behaviour in gay men

Swiss study finds moderate drug resistance; highlights difficulty of interpreting trends in changing treatment populations

Circumcision trial shows how HIV and herpes amplify each other: circumcision protects against both

Scottish gay men’s testing rates only slightly increased between 1996 and 2005

High rate of anal HPV infection, low rate of clearance and significant new infections in HIV-positive gay men

HIV-positive women with a weak immune system more likely to have baby with growth retardation

Rate of transmitted drug-resistant HIV stable in France

International AIDS Society names NAM official conference news provider

Body-shape changes and lipid abnormalities common in HIV-positive children and young adults

Incomplete immune recovery still seen in some people with HIV after ten years of therapy

Isoniazid and ARVs reduce TB risk by 90% in two South African clinics

Slow progress in diagnosis and treatment of MDR-TB and XDR-TB

Receive the latest HIV research and conference news